GOLD(COPD指南)2006.pdfVIP

POCKET GUIDE TO COPD DIAGNOSIS, MANAGEMENT, AND PREVENTION A Guide for Health Care Professionals REVISED DECEMBER 2006 Global Initiative for Chronic Obstructive Lung Disease l l I i i i i i i POCKET_GUIDE_06 1/8/07 1:53 PM Page cov1 GOLD Executive Committee A. Sonia Buist, MD, US, Chair Antonio Anzueto, MD, US (representing ATS) Peter Calverley, MD, UK Teresita S. DeGuia, MD, Philippines Yoshinosuke Fukuchi, MD, Japan (representing APSR) Christine Jenkins, MD, Australia Nikolai Khaltaev, MD, Switzerland (representing WHO) James Kiley, PhD, US (representing NHLBI) Ali Kocabas, MD, Turkey Mara Victorina Lopez, MD, Uruguay (representing ALAT) Klaus F. Rabe, MD, PhD, Netherlands Roberto Rodriguez-Roisin, MD, Spain Thys van der Molen, MD, Netherlands Chris van Weel, MD, Netherlands (representing WONCA) GOLD National Leaders Representatives from many countries serve as a network for the dissemination and implementation of programs for diagnosis, management, and prevention of COPD. The GOLD Executive Committee is grateful to the many GOLD National Leaders who participated in discussions of concepts that appear in GOLD reports, and for their comments during the review of the 2006 Global Strategy for the Diagnosis, Management, and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease Pocket Guide to COPD Diagnosis, Management, and Prevention POCKET_GUIDE_06 1/8/07 1:53 PM Page 1 TABLE OF CONTENTS PREFACE KEY POINTS WHAT IS CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)? RISK FACTORS: WHAT CAUSES COPD? DIAGNOSING COPD Figure 1: Key Indicators for Considering a COPD Diagnosis Figure 2: Normal Spirogram and Spirogram Typical of Patients with Mild to Moderate COPD Figure 3: Differential Diagnosis of COPD COMPONENTS OF CARE: A COPD MANAGEMENT PROGRAM Component 1: Assess and Monitor Disease Component 2: Reduce Risk Factors Figure 4: Strategy to Help a Patient Quit Smoking Component 3: Manage Stable COPD Patient Education Pharmacologic Treat